ARDSLEY ADVISORY PARTNERS LP 13D and 13G filings for Marrone Bio Innovations, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-08 5:09 pm Purchase | 2021-12-31 | 13G | Marrone Bio Innovations, Inc. MBII | ARDSLEY ADVISORY PARTNERS LP | 18,335,767 10.350% | 2,384,631 (+14.95%) | Filing |
| 2021-02-12 5:19 pm Sale | 2020-12-31 | 13D | Marrone Bio Innovations, Inc. MBII | ARDSLEY ADVISORY PARTNERS LP | 15,951,136 9.400% | -1,164,139 (-6.80%) | Filing |
| 2020-02-07 2:27 pm Purchase | 2019-12-31 | 13D | Marrone Bio Innovations, Inc. MBII | ARDSLEY ADVISORY PARTNERS LP | 17,115,275 12.410% | 1,457,195 (+9.31%) | Filing |